$YCBDAug 3, 2026, 3:28 PMAI processed
cbdMD says Senate spending bill would delay federal hemp restrictions, protecting full‐spectrum CBD
AI Summary
CbdMD (YCBD) welcomed Senate Appropriations text released Aug. 2 that would push the federal hemp definition changes slated for Nov. 12 back to Dec. 11, temporarily preserving the current framework for naturally derived full‐spectrum CBD while still allowing a carve‐out for certain synthetic cannabinoids. The company says its core full‐spectrum, naturally derived portfolio should be covered but cautioned the language is not yet law — the House passed a version without the hemp protections, so the provision must survive final reconciliation and the President's signature.
Positives
- Senate continuing resolution text would delay hemp rule changes from Nov. 12 to Dec. 11
- Measure would temporarily preserve access to naturally derived full‑spectrum CBD products
- cbdMD says its core portfolio falls within the category the Senate text intends to protect
Negatives
- Senate text is not law; House passed a different continuing resolution without hemp protections
- Delay is temporary (through Dec. 11) and not a permanent regulatory fix
- Bill includes a carve‑out that could still restrict certain synthetic cannabinoids